Julien Dodet
Chief Executive Officer at Orano Med LLC
Profile
Julien Dodet is associated with three companies, namely Orano Med LLC, Orano Med SAS, and Orano Cycle SA. He is currently serving as the President & Chief Executive Officer of Orano Med LLC and President, CEO & Member-Governors Board of Orano Med SAS.
Additionally, he is also serving as the Director of Orano Cycle SA since 2019.
Julien Dodet active positions
| Companies | Position | Start |
|---|---|---|
Orano Med LLC
 Orano Med LLC Medical SpecialtiesHealth Technology Orano Med LLC develops targeted cancer therapies using lead-212 (212Pb). The company is based in Bethesda, MD. The company is ultimately controlled by the Government of France. The CEO of the company is Julien Dodet. | Chief Executive Officer | - |
Orano Cycle SA
 Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Director/Board Member | 2019-12-13 |
Orano Med SAS
 Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Orano Cycle SA
Orano Cycle SA Other Metals/MineralsNon-Energy Minerals Orano Cycle SA provides nuclear fuel cycle services. It specializes in uranium mining conversion and enrichment. The company is headquartered in Chatillon, France. | Non-Energy Minerals |
Orano Med LLC
Orano Med LLC Medical SpecialtiesHealth Technology Orano Med LLC develops targeted cancer therapies using lead-212 (212Pb). The company is based in Bethesda, MD. The company is ultimately controlled by the Government of France. The CEO of the company is Julien Dodet. | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Orano Med SAS is a French biotechnology company that utilizes nuclear technology to develop new therapies for cancer patients with resistant forms of cancer. The company is based in Châtillon, France, and the CEO of the company is Julien Dodet. The company specializes in targeted alpha therapy treatments, which combines biological molecules to target cancer cells with the properties of lead-212 (212pb) to destroy them while limiting the impact on surrounding healthy cells. Orano Med has formed collaborations with prestigious institutions and biopharmaceutical companies to develop several treatments using 212pb combined with various targeting agents. The company has 212pb manufacturing facilities, laboratories, and R&D centers in France and the United States and is currently investing to expand its GMP-manufacturing capacities for 212pb radiolabeled pharmaceuticals. Orano Med is ultimately controlled by the Government of France. | Health Technology |
- Stock Market
- Insiders
- Julien Dodet
